Document is current
Any future updates will be listed below
-
Authors
Iwami, Daiki https://orcid.org/0000-0002-8274-848X
Matsumoto, Takenao
Ono, Kota
Hotta, Kiyohiko
Ota, Minoru
Chiba, Yuki
Sasaki, Hajime
Hirose, Takayuki
Higuchi, Haruka
Takada, Yusuke
Iwahara, Naoya
Murai, Sachiyo
Shinohara, Nobuo
-
Funding
Funding for this research was provided by:
novartis foundation (japan) for the promotion of science
- License Information
-
More Information
Article History
Received: 14 June 2021
Accepted: 14 October 2021
First Online: 26 October 2021
Declarations
:
: This study was approved by the Hokkaido University Hospital institutional review board (No. 014-0266) and written informed consent was obtained from each patient. The study protocol adhered to the statutes of the Declaration of Helsinki. This trial was registered at the University hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) as UMIN000017605 [].
: Informed consent for publication was obtained from each participant of the study.
: Kota Ono is an employee of AbbVie GK. However, being part of the company has not influenced the results and discussion in this paper. The other authors declare that they have no competing interests (both financial and non-financial) related to this manuscript.
